Stada Group
Surangana Sureka is a seasoned professional with extensive experience in strategy and operations within the pharmaceutical sector. Currently serving as Senior Director and Global Head of Strategy & Operations for Specialty at STADA Group since March 2021, Surangana focuses on business development, strategic partnerships, and commercial excellence. Prior roles include Commercial Director - Specialty / Biosimilars and Director of Strategy & Chief of Staff to the CEO at ZS, where Surangana led projects that crafted go-to-market strategies and facilitated digital transformation for prominent pharmaceutical clients, particularly in rare diseases and women's healthcare. Educational credentials include a Master's Degree in Economics from The London School of Economics and Political Science and a Master of Arts in Economics and Mathematics from the University of Glasgow.
This person is not in any teams
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.